(19)
(11) EP 4 815 948 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24896870.3

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 31/465(2006.01)
A24B 3/14(2006.01)
A24B 15/32(2006.01)
 A24B 3/12(2006.01)
A24B 15/16(2020.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A24B 15/406; A24B 15/42; A24B 15/186; A24B 15/243; A24F 23/02
(86) International application number:
PCT/IB2024/061888
(87) International publication number:
WO 2025/114902 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.11.2023 US 202363602732 P

(71) Applicant: Esolate IP Holdings Ltd
Burlington, Ontario L7L 6A3 (CA)

(72) Inventors:
  • JACKSON, Hardin
    Burlington, Ontario L7L 6A3 (CA)
  • MACHIN, Devin
    Burlington, Ontario L7L 6A3 (CA)
  • OH, Jinhee
    Burlington, Ontario L7L 6A3 (CA)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) COMPOSITIONS AND PRODUCTS FOR IMPROVED ORAL DELIVERY OF NICOTINE AND METHODS OF MAKING AND USING SAME